Recent insights into the roles of nitric oxide and reninangiotensin in the pathophysiology of preeclamptic pregnancy

Seminars in Nephrology

Volumn 18, Issue 2, 1998, Pages 208-230

  Baylis, Chris ^a,b   Beinder, Ernst ^a,c   Sütö, Tamás ^a,c   August, Phyllis ^a,d  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PREECLAMPSIA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; UTERUS BLOOD FLOW; VASOCONSTRICTION; VASODILATATION;

FEMALE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM;

EID: 0031939959     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (235)

1. De Swiet M: The physiology of normal pregnancy, in Rubin PC (ed): Handbook of Hypertension: Hypertension in Pregnancy, vol 10. New York, NY, Elsevier Publishers, 1988, pp 1-9
2. Lindheimer MD, Katz AI: Normal and abnormal pregnancy, in Arieff AI, DeFronzo R (eds): Fluid, Electrolyte and Acid-Base Disorders. New York, NY, Churchill Livingstone, Inc. 1985, pp 1041-1080
3. Chesley LC: Hypertensive Disorders in Pregnancy. New York, NY, Appleton-Century-Crofts, 1978
4. Bader ME, Bader RA: Cardiovascular hemodynamics in pregnancy and labor. Clin Obstet Gynecol 1:924-939, 1968
5. Wilson M, Morganti AA, Zervoudakis et al: Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med 68:97, 1980
6. August P, Lenz T, Ales KL, et al: Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: Deviations related to development of superimposed preeclampsia. Am J Obstet Gynecol 163:1612-21, 1990
7. Davison JM, Noble MCB: Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. Br J Obstet Gynecol 88:10, 1980
8. Davison JM, Dunlop M: Renal hemodynamics and tubular function in normal human pregnancy. Kidney Int 18:152-161, 1980
9. Baylis C: Glomerular filtration and volume regulation in gravid animal models, in Lindheimer MD, Davison JM (eds): Baillieres Clinical Obstetrics and Gynecology, Vol 8, 2nd ed. London, Bailliere Tindall, 1994, pp 235-264
10. Roberts M, Lindeheimer MD, Davison JM: Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy. Am J Physiol F338-F343, 1996
11. Moncada S, Palmer RMJ, Higgs EA: Biosynthesis and endogenous roles of nitric oxide. Pharmacol Rev 43:109-142, 1991
12. Kone B, Baylis C: Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 272 (Renal Physiology 41):F561-F578, 1997
13. Conrad KP, Whittemore SL: NG-monomethyl-L-arginine and nitroarginine potentiate presser responsiveness of vasoconstrictors in conscious rats. Am J Physiol 262:R1137-R1144, 1992
14. Baylis C, Vallance P: Nitric oxide and blood pressure; effects of NO deficiency. Curr Opin Nephrol Hypertens 5:80-88, 1996
15. Haynes WG, Noon JP, Walker BR, et al: Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 11:1375-1380, 1993
16. Haynes WG, Hand MF, Dockrell MEC, et al: Physiological role of nitric oxide in regulation of renal function in humans. Am J Physiol F364-F371, 1997
17. Baylis C, Harton P, Engels K: Endothelial derived relaxing factor (EDRF) controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1:875-881, 1990
18. Kanno K, Hirata Y, Emori T, et al: L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 19:619-625, 1992
19. Reyes AA, Karl IE, Klahr S: Role of arginine in health and in renal disease. Am J Physiol 267:F331-F346, 1994
20. Schmidt RJ, Samsell LJ, Sorkin MI, et al: Nitric oxide (NO) production in peritoneal dialysis patients (PDF). J Am Soc Nephrol 6:1030, 1995
21. Panza JA, Quyyumi AA, Brush JE Jr, et al: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N EngI J Med 323:22-27, 1990
22. Hishikawa K, Nakaki T, Suzuki H, et al: Role of Larginine-nitric oxide pathway in hypertension. J Hypertens 11:639-645, 1993
23. Maxwell AJ, Cooke JP: Cardiovascular effects of Larginine Recent Advances. Curr Opin Nephrol Hypertens (in press) 1998
24. Conrad KP, Vernier KA: Plasma levels, urinary excretion and metabolic production of cGMP during gestation in rats. Am J Physiol 257:R847-R853, 1989
25. Arnal Jean-Francois, Warin L, Michel Jean-Baptiste: Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 90:647-652, 1992
26. Losonczy Gy, Bloch JF, Samsell L, et al: Impact of surgery on nitric oxide in rats; evidence for activation of inducible NO synthase. Kidney Int 51:1943-1949, 1997
27. X) levels in plasma and urine; what does this measure tell us about the activity of the endogenous nitric oxide. Curr Opin Nephrol Hypertens (in press) January 1998
28. Conrad KP, Joffe GM, Kruszyna H, et al: Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 7:566-571, 1993
29. Deng A, Engels K, Baylis C: Increased nitric oxide production plays a critical role in the maternal blood pressure and glomerular hemodynamic adaptations to pregnancy in the rat. Kidney Int 50:1132-1138, 1996
30. Suto T, Lateef A, Baylis C: Effect of different nitric oxide synthesis (NOS) inhibitors on NO production and blood pressure (BP) in pregnancy (P). Hypertens Pregn 16:68, 1997
31. Lubarsky SL, Ahokas RA, Friedman SA, Sibai BM: The effect of chronic nitric oxide synthesis inhibition on blood pressure and angiotensin II responsiveness in the pregnant rat. Am J Obstet Gynecol 176:1069-1076, 1997
32. Weiner CP, Knowles RG, Moncada S: Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 171:838-843, 1994
33. Weiner CP, Lizasoain I, Baylis SA, et al: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci 91:5212-5216, 1994
34. Goetz RM, Morano I, Calovini T, et al: Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun 205:905-910, 1994
35. Xu DL, Martin PY, St. John J, et al: Upregulation of endothelial and neuronal constitutive nitric oxide synthase in pregnant rats. Am J Physiol 271:R1739-R1745, 1996
36. Magness RR, Shaw CE, Phernetton TM, et al: Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expression. Am J Physiol H1730-H1740, 1996
37. Magness RR, Rosenfeld CR, Hassan A, et al: Endothelial vasodilator production by uterine and systemic arteries: I. Effects of ANG II on PGI2 and NO in pregnancy. Am J Physiol 270:H1914-H1923, 1996
38. Boegehold M: Heterogeneity of endothelial function within the circulation. Curr Opin Nephrol Hypert (in press) 1998
39. Baylis C, Conrad K, Suto T: Nitric oxide in normal and pre-eclamptic pregnancy. Hypertens Pregn 15:147-169, 1996
40. Sladek SM, Magness RR, Conrad KP: Nitric oxide and pregnancy. Am J Physiol 272:R441-R463, 1997
41. Poston L, McCarthy L, Ritter JM: Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther 65:215-239, 1995
42. Weiner CP, Martinez E, Chestnut DH, et al: Effect of pregnancy on uterine and carotid artery response to norepinephrine, epinephrine, and phenylephrine in vessels with documented functional endothelium. Am J Obstet Gynecol 161:1605-1610, 1989
43. Weiner CP, Thompson LP, Liu KZ, et al: Pregnancy reduces serotonin-induced contraction of puinea pig uterine and carotid arteries. Am J Physiol 263:H1764-H1769, 1992
44. Weiner CP, Thompson LP, Liu KZ, et al: Endothelium-dervived relaxing factor and indomethacin-sensitive contracting factor alter arterial contractile responses to thromboxane during pregnancy. Am J Obstet Gynecol 166:1171-1181, 1992
45. St-Louis J, Sicotte B: Prostaglandin- or endothelium-mediated vasodilation is not involved in the blunted responses of blood vessels to vasoconstrictors in pregnant rats. Am J Obstet Gynecol 166:684-692, 1992
46. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, et al: Contraction and endothelium-dependent relaxation in mesenteric microvessels from pregnant rats. Am J Physiol 269:H1899-H1904, 1995
47. Davidge ST, McLaughlin MK: Endogenous modulation of the blunted adrenergic response in resistance sized mesenteric arteries from the pregnant rat. Am J Obstet Gynecol 167:1691-1698, 1992
48. Nathan L, Cuevas J, Chaudhuri G: The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol 114:955-960, 1995
49. Umans JG, Lindheimer MD, Barron WM: Pressor effect of endothelium derived relaxing factor inhibition in conscious virgin and gravid rats. Am J Physiol 259:F293-F296, 1990
50. Molnar M, Hertelendy F: Nw-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 166:1560-1567, 1992
51. Danielson LA, Conrad KP: Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest 96:482-490, 1995
52. Alien R, Castro L, Arora C, et al: Endothelium-derived relaxing factor inhibition and the presser response to norepinephrine in the pregnant rat. Obstet Gynecol 83:92-96, 1994
53. Losonczy GY, Mucha I, Muller V, et al: The vasoconstrictor effects of L-NAME, a nitric oxide synthase inhibitor, in pregnant rabbits. Br J Pharmacol 118:1012-1018, 1996
54. Coelho EB, Ballejo G, Salgado MCO: Nitric oxide blunts sympathetic response of pregnant normotensive and hypertensive rat arteries. Hypertension 30:585-588, 1997
55. Honda H, Kaneko H, Kondo M, et al: Comparison of endothelium-derived relaxing factor activity between nonpregnant and pregnant rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 114:193-196, 1996
56. Tresham JJ, Boutros P, Wintour EM, et al: Role of nitric oxide in the attenuated pressor responses of pregnant or sodium-deplete sheep. J Cardiovasc Pharmacol 27:908-915, 1996
57. Yamasaki M, Lindheimer MD, Umans JG: Effects of pregnancy on femoral microvascular responses in the rat. Am J Obstet Gynecol 175:730-736, 1996
58. Baylis C, Engels K: Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clin Exp Hypertens B11:117-129, 1992
59. Diket AL, Pierce MR, Munshi UK, et al: Nitric oxide inhibition casuses intrauterine growth retardation and hind-limb distruptions in rats. Am J Obstet Gynecol 171:1243-1250, 1994
60. Yallampalli C, Garfield RE: Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 169:1316-1320, 1993
61. Molnar M, Suto T, Toth T, et al: Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 170:1458-1466, 1994
62. Richer C, Boulanger H, Es-Slami S, et al: Lack of beneficial effects of the NO-donor, molisdomine, in the L-NAME-induced pre-eclamptic syndrome in pregnant rats. Br J Pharmacol 199:1642-1648, 1996
63. Salas SP, Altermatt F, Campos M, et al: Effects of long-term nitric oxide synthesis inhibition on plasma volume expansion and fetal growth in the pregnant rat. Hypertension 26:1019-1023, 1995
64. Takeda T: Experimental study on the blood pressure of pregnant hypertensive rats. Jpn Cire J 28:49-54, 1964
65. Gandley RE, Conrad KP, McLauhlin MK: Nitric oxide regulates myogenic behaviour in the renal resistance vasculature at mid pregnancy in the rat. J Soc Obstet Gynecol 3:100A, 1996 (abstr)
66. Griggs KC, Conrad KP, Mackey K, et al: Endothelial modulation of renal interlobar arteries from pregnant rats. Am J Physiol 265:F309-F315, 1993
67. Danielson LA, Conrad KP: Prostaglandins maintain renal vasodilation and hyperfiltration during chronic nitric oxide synthase blockade in conscious pregnant rats. Circ Res 79:1161-1166, 1996
68. Wolff DJ, Lubeskie A: Aminoguanidine is an isoformselective, mechanism-based inactivator of nitric oxide synthase. Arch Biochem Biophysics 316:290-301, 1995
69. Misko TP, Moore WM, Kasten TP, et al: Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharm 233:119-125, 1993
70. Laszlo F, Evans SM, Whittle BJR: Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharm 272:169-175, 1995
71. Raij L: Glomerular thrombosis in pregnancy: Role of the L-arginine-nitric oxide pathway. Kidney Intl 45:775-781, 1994
72. Pau MY, Milner JA: Arginine deficiency during gestation and lactation in the rat. J Nutr 111:184-193, 1981
73. Conger JD, Falk SA, Guggenheim SJ: Glomerular dynamics and morpologic changes in the generalized shwartzman reaction in postpartum rats. J Clin Invest 67:1334-1346, 1981
74. Faas MM, Schuiling GA, Bailer JFW, et al: Glomerular inflammation in pregnant rats after infusion of low dose endotoxin. Am Pathol 147:1510-1518, 1995
75. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Consensus Report. Am J Obstet Gynecol 163:1689-1712, 1990
76. Baylis C: Immediate and long term renal effects of pregnancy in the spontaneously hypertensive rat (SHR). Am J Physiol 257:F1140-F1145, 1989
77. Deng A, Baylis C: Glomerular hemodynamic responses to pregnancy in the rat with severe reduction of renal mass. Kidney Int 48:39-44, 1995
78. Podjamy E, Bernheim J, Rathaus M, et al: Adriamycin nephropathy: A model to study effects of pregnancy on renal disease in rats. Am J Physiol F711-F715, 1992
79. Podjamy E, Pomeranz A, Rathaus M, et al: Effect of L-arginine treatment in pregnant rats with adriamycin nephropathy. Hypertens Pregn 12:517-524, 1993
80. Bemheim J, Podjarny E, Pomeranz A, et al: Pregnancy-induced hypertension in rats with early adriamycin nephropathy. Nephrol Dial Transplant Suppl 3:13-16, 1994
81. Podjamy E, Ben-Chetrit S, Rathaus M, et al: Pregnancy-induced hypertension in rats with adriamycin nephropathy is associated with an inadequate production of nitric oxide. Hypertension 29:986-991, 1997
82. Florin TH, Neale G, Cummings JH: The effect of dietary nitrate on nitrate and nitrite excretion in man. Br J Nutrition 64:387-397, 1990
83. Committee on Nitrate and Alternative Curing Agents in Food, National Academy of Sciences. The health effects of nitrate, nitrite and n-nitroso compounds. Natl. Acad. Press, Washington, DC, 1981
84. NOxV) do not predict renal vascular NO production. Kidney Int 48:1272-1277, 1995
85. Kopp L, Paradiz G, Tucci JR: Urinary excretion of cyclic 3′,5′-adenosine monophosphate and cyclic 3′,5′-quanosine monophosphate during and after pregnancy. J Clin Endocrinol Metab 44:590-594, 1977
86. Schneider F, Lutun P, Baldauf JJ, et al: Plasma cyclic GMP concentrations and their relationship with changes of blood pressure levels in pre-eclampsia. Acta Obstet Gynecol Scand 75:40-44, 1996
87. Boccardo P, Soregaroli M, Aiello S, et al: Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 103:879-886, 1996
88. López-Jaramillo P, Narváez M, Calle A, et al: Cyclic guanosine 3′, 5′ monophosphate concentrations in preeclampsia: effects of hydralazine. Br J Obstet Gynaecol 103:33-38, 1996
89. Begum S, Yamasaki M, Mochizuki M: The role of nitric oxide metabolites during pregnancy. Kobe J Med Sci 42:131-141, 1996
90. Gregoire I, EI Esper N, Gondry J, et al: Plasma atrial natriuretic factor and urinary excretion of a ouabain displacing factor and dopamine in normotensive pregnant women before and after delivery. Am J Obstet Gynecol 162:71-76, 1990
91. Morris NH, Carroll S, Nicolaides KH, et al: Exhaled nitric oxide concentration and amniotic fluid nitrite concentration during pregnancy. Eur J Clin Invest 25:138-141, 1995
92. Seligman SP, Buyon JP, Clancy RM, et al: The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 171:944-948, 1994
93. Curtis NE, Gude NM, King RG, et al: Nitric oxide metabolites in normal human pregnancy and pre-eclampsia. Hypertens Pregn 14:339-349, 1995
94. Nobunaga T, Tokugawa Y, Hashimoto K, et al: Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest 41:189-193, 1996
95. Smdrason AK, Allman KG, Young D, et al: Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia. Br J Obstet Gynaecol 104:538-543, 1997
96. Conrad KP, Mosher MD: Nitric oxide biosynthesis in normal and pre-eclamptic pregnancies. A preliminary report. J Am Soc Nephrol 6:657, 1995
97. Brown MA, Tibben E, Zammit VC, et al: Nitric oxide excretion in normal and hypertensive pregnancies. Hypertens Pregn 14:319-326, 1995
98. Delacretaz E, de Quay N, Waeber B, et al: Differential nitric oxide synthase activity in human platelets during normal pregnancy and pre-eclampsia. Clin Sei 88:607-610, 1995
99. Keaney JF, Simon DI, Stamler JS, et al: NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 91:1582-1589, 1993
100. Hytten FE, Cheyne GA: The aminoaciduria of pregnancy. Br J Obstet Gynecol 79:429-432, 1992
101. Domenech M, Gruppuso PA, Nishino VT, et al: Preserved fetal plasma aminoacid concentrations in the presence of maternal hypoaminoacidemia. Pediatr Res 20:1071-1076, 1986
102. Ghadimi H, Pecora P: Free amino acids of cord plasma as compared with maternal plasma during pregnancy. Pediatrics 500-506, 1964
103. Wood MH, O'Sullivan WJ: The orotic aciduria of pregnancy. Am J Obstet Gynecol 116:57-61, 1973
104. Pickling SA, Williams D, Vallance P, et al: Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia. Lancet 342:242-243, 1993
105. McCarthy AL, Taylor P, Graves J, et al: Endothelium-dependent relaxation of human resistance arteries in pregnancy. Am J Obstet Gynecol 171:1309-1315, 1994
106. Knock GA, Poston L: Bradykinin mediated relaxation of isolated maternal reistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 175:1668-1674, 1996
107. Pascoal IF, Umans JG: Effect of pregnancy on mechanisms of relaxation in human omental microvessels. Hypertension 28:183-187, 1995
108. Cockell AP, Poston L: Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 30:247-251, 1997
109. Williams DJ, Vallance PJT, Neild GH, et al: Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 272:H748-H752, 1997
110. Ford GA, Robson SC, Mahdy ZA: Superficial hand vein responses to NG-monomethy I-L arginine in post-partum and non-pregnant women. Clin Sci 90:493-497, 1996
111. Bell DR, Rensberger HJ, Koritnik DR, et al: Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am J Physiol 268:H377-H383, 1995
112. Gisclard V, Miller VM, Vanhoutte PM: Effect of 17β- estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 244:19-22, 1988
113. Foegh ML, Ramwell PW: Cardiovascular effects of estrogen-Implications of the [missing text?]. Curr Opin Nephrol Hypertens 7 (in press) 1998
114. Farhat MY, Abi-Younes S, Ramwell PW: Nongenomic effects of estrogen on the vessel wall. Biochem Pharmacol 51:571-576, 1996
115. Garland HO, Atherton JC, Baylis C, et al: Hormone profiles for progesterone, estradiol, prolactin, plasma renin activity, aidosterone and corticosterone during pregnancy and pseudopregnancy in two strains of rats; Correlation with renal studies. J Endocrinol 113:435-444, 1987
116. Mastrobattista JM, Skupski DW, Monga M, et al: The rate of severe preeclampsia is increased in triplet as compared to twin gestations. Am J Perinatol 14:263-265, 1997
117. Robertson WB, Brosens I, Dixon G: Maternal unterine vascular lesions in the hypertensive complications of pregnancy, in Lindheimer MD, Katz AI, Zuspan FP (eds): Hypertension in Pregnancy. New York, NY, John Wiley, 1976, pp 115-129
118. Pijnenborg R: Trophoblast invasion and placentation in the human: Morphological aspects. Trophoblast Res 4:33-47, 1990
119. Zhou Y, Damsky CH, Fisher SJ: Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. J Clin Invest 99:2152-2164, 1997
120. Roberts JM, Taylor RN, Musci TJ, et al: Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 161:1200-1204, 1989
121. Hennessy A, Gillin A, Horvath J: Cardiovascular research in pregnancy: The role of animal models. Hypertens Pregn 12:413-437, 1993
122. Barton JR, Sibai BM, Ahokas RS, et al: Magnesium sulphate therapy in preeclampsia is associated with increased urinary cGMP excretion. Am J Obstet Gynecol 167:931-934, 1992
123. Cameron IT, Van Papendorp CL, Palmer RMJ, et al: Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregn 12:85-92, 1993
124. Silver RK, Kupfermine MJ, Russell TL, et al: Evaluation of nitric oxide as a mediator of severe preeclampsia. Am J Obstet Gynecol 175:1013-1017, 1996
125. Davidge ST, Stranko CP, Roberts JM: Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 174:1008-1013, 1996
126. McCarthy AL, Woolfson RG, Raju SK, et al: Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 168:1323-1330, 1993
127. DeBelder AJ, Lees C, Martin J, et al: Treatment of HELLP syndrome with nitric oxide donor. Lancet 345:124-125, 1995
128. Hardy E, Rubin PC, Horn EH: Effects of nitric oxide donors in vitro on the arachidonic acid-induced platelet release reaction and platelet cyclic GMP concentration in preeclampsia. Clin Sci 85:195-202, 1994
129. Davidge ST, Signorella AP, Hubel CA, et al: Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension 28:758-764, 1996
130. Baker PN, Stranko CP, Davideg ST, et al: Mechanical stress eliminates the effects of plasma from patients with preeclampsia on endothelial cells. Am J Obstet Gynecol 174:730-736, 1996
131. Arngrímsson R, Hayward C, Nadaud S, et al: Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet 61:354-362, 1997
132. Rosenfeld CR: Changes in uterine blood flow during pregnancy, in Rosenfeld CR (ed): The Uterine Circulation, Ithaca, NY, Perinatology, 1989, pp 135-156
133. Rankin JHG, Goodman A, Phernetton T: Local regulation of the uterine blood flow by the umbilical circulation. Proc Soc Exp Biol Med 50:690-694, 1975
134. Stock MK, Anderson DF, Phernetton TN, et al: Vascular response of the fetal placenta to local occlusion on the maternal placental vasculature. J Devl Physiol 2:339-344, 1980
135. Trudinger BJ, Cook CM: Doppler umbilical and uterine flow waveforms in severe pregnancy hypertension. Br J Obstet Gynecol 97:142-148, 1990
136. Magness RR, Shaw CE, Phernetton TM, et al: Endothelial vasodilator production by uterine and systemic arteries: II. Effects of pregnancy on nitric oxide synthase expression. Am J Physiol 272(4Pt2):H1730-H1740, 1997
137. 2 and NO in pregnancy. Am J Physiol 270:H1914-H1923, 1996
138. Li P, Tong C, Eisenach JC: Pregnancy and ephedrine increase release of nitric oxide in ovine uterine arteries. Anaesth Analg 82:288-293, 1996
139. Venema RC, Sayegh HS, Kent JD, et al: Identification, characterization and comparison of the calmodulin binding domains of the endothelial and inducible nitric oxide synthases. J Biol Chem 271:6435-6440, 1996
140. Mohaupt MG, Beinder E, Schlembach D, et al: Functional changes and altered endothelial nitric oxide synthase expression in pregnancy with preeclampsia. (Submitted for publication)
141. Greiss Jr FC, Gobble FL, Anderson SG, et al: Effect of acetylcholine on the uterine vascular bed. Am J Obstet Gynecol 99:1073-1077, 1967
142. Resnik R, Killam AP, Barton MD, et al: The effect of various vasoactive compounds upon the uterine vascular bed. Am J Obstet Gynecol 125:201-206, 1976
143. Nelson SH, Steinsland OS, Johnson RL, et al: Pregnancy-induced alterations of neurogenic constriction and dilation of the human uterine artery. Am J Physiol 268:H1694-H1701, 1995
144. Ni Y, Meyer M, Osol G: Gestation increases nitric oxide-mediated vasodilation in rat uterine arteries. Am J Obstet Gynecol. Am J Obstet Gynecol 176:856-864, 1997
145. Ramsay B, DeBelder A, Campbell S, et al. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of preeclampsia. Eur J Clin Invest 24:76-78, 1996
146. Bell C: Estrogen-induced sensitization of the uterine artery of the guinea-pig to acetylcholine. Br J Pharacol 49:595-601, 1973
147. Bell C, Coffey C: Factors influencing estrogen-induced sensitization to acetylcholine of guinea pig artery. J Reprod Fertil 66:133-137, 1982
148. Veille JC, Li P, Eisenach JC, et al: Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vivo. Am J Obstet Gynecol 174:1043-1049, 1996
149. Randall NJ, Beard RW, Sutherland IA, et al: Validation of thermal techniques for measurement of pelvic organ blood flows in the nonpregnant sheep: Comparison with transit-time ultrasonic and microsphere measurement of blood flow. Am J Obstet Gynecol 158:651-658, 1988
150. Van Buren GA, Yang D, Clark KE: Estrogen-induced uterine vasodilatation is antagonized by N-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 167:828-833, 1992
151. Robertson WB, Khong TY, Brosens I, et al: The placental bed biopsy: Review from three European centers. Am J Obstet Gynecol 155:401-412, 1986
152. Nicolaides KH, Economides DL, Soothill PW: Blood gases, pH, and lactate in appropriate and small for gestational age fetuses. Am J Obstet Gynecol 61:996-1001, 1989
153. Myatt L, Brockman DE, Eis ALW, et al: Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 14:487-495, 1993
154. Buttery LDK, McCarthy A, Springall DR, et al: Endothelial nitric oxide synthase in the human placenta: Regional distribution and proposed regulatory role at the fetomaternal interface. Placenta 15:257-265, 1994
155. Kaufmann P: Development and differentiation of the human placental villous tree. Bibliotheca Anat 22:29-39, 1982
156. Myatt L, Brockman DE, Langdon G, et al: Constitutive calcium-dependent isoform of nitric oxide synthase in the human placental villous vascular tree. Placenta 14:373-383, 1993
157. Garvey EP, Tuttle JV, Covington K, et al: Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch Biochem Biophys 311:235-241, 1994
158. Conrad KP, Vill M, Mc Guire PG, et al: Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi. FASEB J 7:1269-1276, 1993b
159. Conrad KP, Davis AK: Nitric oxide synthase activity in placentae from women with preeclampsia. Placenta 16:691-699, 1995
160. Schönfelder G, John M, Hopp H, et al: Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes. FASEB J 10:777-784, 1996
161. Ghabour MS, Eis ALW, Brockman DE, et al: Immunohistochemical characterization of placental nitric oxide expression in preeclampsia. Am J Obstet Gynecol 173:687-694, 1995
162. Rutherford RAD, McCarthy A, Sullivan MHF, et al: Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth retarded and pre-eclamptic pregnancies. Br J Pharmacol 116:3099-3109, 1995
163. Wang Y, Walsh SW, Pamell R, et al: Placental production of nitric oxide and endothelin in normal and preeclamptic pregnancies. Hypertens Pregn 13:171-178, 1994
164. Lyall F, Young A, Greer IA: Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 173:714-718, 1995
165. Morris NH, Sooranna SR, Learmont JG, et al: Nitric oxide in placental tissue from normotensive, preeclamptic and growth retarded pregnancies. Br J Obstet Gynecol 102:711-714, 1995
166. King RG, Di lulio JL, Gude NM, et al: Effect of asymmetric dimethyl arginine on nitric oxide synthase activity in normal and pre-eclamptic placentae. Reprod Fertil Dev 7:1581-1584, 1995
167. Brennecke SP, Gude NM, Di Iulio JL, et al: Reduction of placental nitric oxide synthase activity in pre-eclampsia. Clin Sci 93:51-55, 1997
168. Giles W, O'Callaghan S, Gude N, et al: Placental nitric oxide synthase activity and abnormal umbilical artery flow velocity waveforms. Obstet Gynecol 89:49-52, 1997
169. Learmont JG, Poston L: Nitric oxide is involved in flow-induced dilation of isolated human small fetoplacental arteries. Am J Obstet Gynecol 174:583-588, 1996
170. Maigaard S, Forman A, Andersson KE: Digoxin inhibition of relaxation induced by prostacyclin and vasoactive intestinal polypeptide in small human placental arteries. Placenta 6:435-443, 1985
171. Myatt L, Brewer AS, Brockman DE: The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 164:687-692, 1991
172. Chaudhuri G, Furuya K: Endothelium-derived vasoactive substances in fetal placental vessels. Semin Perinatol 15:63-67, 1991
173. Monuszko E, Halevy S, Freese KJ, et al: Umbilical vessels endothelium and vascular reactivity. Microcirc Endothel Lymph 6:183-208, 1990
174. Van de Voorde J, Vanderstichele H, Leusen I: Release of endothelium-derived relaxing factor from human umbilical vessels. Circ Res 60:517-522, 1987
175. Gude NM, King RG, Brennecke SP: Role of endothelium-derived nitric oxide in maintainance of low fetal vascular resistance in placenta. Lancet 336:1589-1590, 1990
176. Myatt L, Brewer AS, Langdon G, et al: Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol 166:224-230, 1992
177. Akar F, Ark M, Uydes BS, et al: Nitric oxide production by human umbilical vessels in severe preeclampsia. J Hypertension 12:1235-1241, 1994
178. Pinto A, Sorrentino R, Sorrentino P, et al: Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 164/2:507-513, 1990
179. Gonzalez C, Cruz MA, Gallardo V, et al: Nitric oxide and prostaglandin system inhibition on the isolated perfused human placenta from normal and preeclamptic pregnancies. Gynecol Obstet Invest 40:244-248, 1995
180. Kovacs AG, Makary A, Peto J, et al: Deficiency of cGMP level in placental circulation in pregnancy-induced hypertensive disorders: Possibility of decreased endothelium-derived relaxing factor. Hypertens Pregn 13:163-169, 1994
181. Sealey JE, McCord D, Taufield PA, et al: Plasma prorenin in first trimester pregnancy: Relationship to changes in human chorionic gonadotropin. Am J Obstet Gynecol 153:514-519, 1985
182. Itskovits J, Sealey JE, Glorioso N, et al: Plasma prorenin to hCG in ovarian hyperstimulation women: Correlation with the number of ovarian follicles and steroid hormone concentrations. Proc Natl Acad Sci USA 84:7285-7289, 1987
183. Sealey JE, Glorioso N, Itskovitz J, et al: Plasma prorenin during early pregnancy: Ovarian secretion under gonadotropin control? J Hypertens 4:S92-S95, 1986 (Suppl 5)
184. Brar HS, Do Y-S, Tam HB, et al: Uteroplacental unit as a source of elevated circulating prorenin levels in normal pregnancy. Am J Obstet Gynecol 155:1223-1226, 1986
185. Shaw KJ, Do YS, Kjos S, et al: Human decidua is a major source of renin. J Clin Invest 83:2085-2092, 1989
186. Poisner Am, Words GW, Poisner R, et al: Localization of renin in trophoblasts in human chorion laeve at term pregnancy. Endocrinology 109:1150-1154, 1981
187. Soubrier F, Panthier JT, Corvol P, et al: Molecular cloning and nucleotide sequence of a human renin and DNA fragment. Nucleic Acid Res 20:7187-7190, 1983
188. Skinner SI, Cran EJ, Givson R, et al: Angiotensin I and II, renin-substrate, renin activity, and angiotensinase in human liqor amnii and plasma. Am J Obstet Gynecol 121:626, 1975
189. Weir RJ, Brown JJ, Fraser R, et al: Relationship between plasma renin, renin substrate angiotensin II, aldosterone and electrolytes in normal pregnancy. J Clin Endocrinol Metab 40:108-115, 1975
190. Tewskbury DA, Tryon ES, Burrill RE, et al: High molecular weight angiotensinogen: A pregnancy associated protein. Clin Chim Acta 158:7-12, 1986
191. Tewskbury DA, Dart RA: High molecular weight angiotensinogen levels in hypertensive pregnant women. Hypertension 4:729-734, 1982
192. Sealey JE, Atlas SA, Glorioso N, et al: Cyclical secretion of prorenin during the menstrual cycle: Synchronization with luteinizing hormone and progesterone. Proc Natl Acad Sci USA 82:8705-8709, 1985
193. Sealey JE, Wilson M, Morganti AA, et al: Changes in active and inactive renin throughout normal pregnancy. Clin Exp Hypertens 4A:2372-2384, 1982
194. August P, Sealey JE: The renin-angiotensin system in normal and hypertensive pregnancy and in ovarian function, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management. New York, NY, Raven Press, 1990, pp 1761-1778
195. Takimioto E, Ishida J, Sugiyama F, et al: Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 274:995-998, 1996
196. Ferns TF, Stein JH, Kaufman J: Uterine blood flow and uterine renin secretion. J Clin Invest 51:2827-2833, 1972
197. Albertini R, Seino M, Scicli AG, et ai: Uteroplacental renin in regulation of blood pressure in the pregnant rabbit. Am J Physiol 239:H266-H271, 1980
198. Abdul-Karim R, Assali NS: Pressor response to angiotensin in pregnant and nonpregnant women. Am J Obstet Gynecol 82:246-251, 1961
199. Gant NF, Whalley PJ, Everett RB, et al: Control of vascular reactivity in pregnancy. Am J Kidney Dis IX:303-307, 1987
200. Gant NF, Daley GL, Chand S, et al: A study of angiotensin II presor response throughout primigravid pregnancy. J Clin Invest 52:2682-2689, 1973
201. Phippard AF, Horvath JS, Glynn EM, et al: Circulatory adaptation to pregnancy- serial studies of hemodynamics, blood volume, renin and aldosterone in the baboon (Papio hamadryas). J Hypertens 4:773-779, 1986
202. Schrier RW: Body fluid volume regulation in health and disease: A unifying hypothesis. Ann Intern Med 113:155, 1990
203. Lindheimer MD, Barren WM, Davison JM: Osmoregulation of thirst and vasopressin release in pregnancy. Am J Physiol 257:F159, 1989
204. August P, Muller FB, Sealey JE, et al: The stimulated renin angiotensin system maintains blood pressure. Lancet 345:896-897, 1995
205. Ferris TF, Weir EK: Effect of captropril on uterine blood flow and prostaglandin synthesis in the pregnant rabbit. J Clin Invest 71:809-815, 1983
206. Hagemann A, Nielsen AH, Poulsen K: The uteroplacental renin-angiotensin system: A review. Exp Clin Endocrinol 102:252-261, 1994
207. Brown JJ, Davies DL, Doak PB, et al: Plasma renin concentration in hypertensive disease of pregnancy. Lancet ii:1219, 1965
208. Tapia HR, Johnson CE, Strong CG: Renin-angiotensin system in normal and in hypertensive disease of pregnancy. Lancet ii:847-850, 1972
209. Weir RJ, Brown JJ, Fraser R, et al: Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease in pregnancy. Lancet 1:291-294, 1973
210. Beilin LJ, Deacon J, Michael CA, et al: Diurnal rhythms of blood pressure, plasma renin activity, angiotensin II and catecholamines in normotensive and hypertensive pregnancies. Clin Exp Hypertens B2:271-293, 1983
211. Brown MA, Zammit VC, Mitar DA, et al: Reninaldosterone relationships in pregnancy-induced hypertension. Am J Hypertesn 5:366-371, 1992
212. Taufield PA, Druzin ML, Edersheim TG, et al: Correlation between plasma renin activity and birthweight in hypertensive pregnancy. J Hypertens 4:S96-S98, 1986 (Suppl 5)
213. Nochy D, Bariety J, Camilleri JP, et al: Diminished number of renin-containing cells in kidney biopsy samples from hypertensive women immediately postpartum. An immunomorphometric study. Kidney Int 26:85-87, 1984
214. Gordon RD, Symonds EM, Wilmhurst EG, et al: Plasma renin activity, plasma angiotensin and plasma and urinary electrolytes in normal and toxaemic pregnancy, including a prospective study. Clin Sei Molec Med 45:115-127, 1973
215. Symonds EM, Broughton Pipkin F, Craven DJ: Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy. Br J Obstet Gynecol 82:643-650, 1975
216. Symonds EM, Broughton Pipkin F: Pregnancy hypertension, parity, and the renin-angiotensin system. Am J Obstet Gynecol 132:473-479, 1978
217. Baker PN, Broughton Pipkin F, Symonds EM: Plate-let angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in normal pregnancy. Clin Sci 79:403-408, 1990
218. Baker PN, Broughton Pipkin F, Symonds EM: Platelet angiotensin II binding in hypertension in pregnancy. Lancet ii:l 151, 1989
219. Graves SW, Moore TJ, Seely EW: Increased platelet angiotensin II receptor number in pregnancy-induced hypertension. Hypertension 20:627-632, 1992
220. Pawlak MA, MacDonald GJ: Altered number of platelet angiotensin II receptors in relation to plasma agonist concentrations in normal and hypertensive pregnancy. J Hypertens 10:813-819, 1992
221. Baker PN, Broughton Pipkin F, Symonds EM: Comparative study of platelet angiotensin binding and the angiotensin II sensitivity test as predictors of pregnancy induced hypertension. Clin Sci 83:89-95, 1992
222. Knock GA, Sullivan MH, McCarthy A, et al: Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J Pharmacol Exp Ther 271:1007-1015, 1994
223. Brown MA, Reiter L, Rodger A, et al: Impaired renin Stimulation in pre-eclampsia. Clin Sci 86:575-581, 1994
224. Kalenga MK, Thomas K, de Gasparo M, et al: Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension. Clin Endocrinol 44:429-433, 1996
225. Chesley LC, Annitto JE, Cosgrove RA: The familial factor in toxemia of pregnancy. Am Coll Obstet Gynecol 32:303-311, 1968
226. Sutherland A, Cooper DW, Howie PW, et al: The incidence of severe 'pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls. Br J Obstet Gynaecol 88:785, 1981
227. Cooper DW, Brennecke SP, Wilton AN: Genetics of preeclampsia. Hypertens Pregn 12:1-23, 1993
228. Arngrimsson R, Bjornsson S, Geirsson RT: Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. Hypertens Pregn 14:27, 1995
229. Ward K, O Hata A, Jeunemaitre X, et al: A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 4:59-61, 1993
230. Arngrimsson R, Purandare S, Connor M, et al: Angiotensinogen: A candidate gene involved in pre-eclampsia? Nature Genet 4:114-115, 1993
231. Jeunemaitre S, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
232. Inoue I, Rohrwasser A, Helin C, et al: A mutation of angiotensinogen in a patient with preeclampsia leads to latered kinetics of the renin-angiotensin system. J Biol Chemistry 270:11430-11436, 1995
233. Arngrimsson R, Geirsson RT, Cooke A, et al: Renin gene restriction fragment length polymorphisms do not show linkage with preeclampsia and eclampsia. Acta Obstet Gynecol Scand 73:10-13, 1994
234. Tamura T, Johanning GL, Goldenberg RL, et al: Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration. Obstet Gynecol 88:497-502, 1996
235. Tamura T, Johanning GL, Goldenberg RL, et al: Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration. Obstet Gynecol 88:497-502, 1996